Table 2 p53 status of UKF-NB-3 and UKF-NB-6 sublines adapted to nutlin-3 in independent experiments

From: Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

UKF-NB-3 sublines

p53 status

UKF-NB-6 sublines

p53 status

UKF-NB-3rNutlin10 μM

G245Ca,b

UKF-NB-6rNutlin10 μM

K132Nc, P223Lb

UKF-NB-3rNutlin10 μM I

Wild type

UKF-NB-6rNutlin10 μM I

S241Fb

UKF-NB-3rNutlin10 μM II

Wild type

UKF-NB-6rNutlin10 μM II

C277Fb

UKF-NB-3rNutlin10 μM III

Wild type

UKF-NB-6rNutlin10 μM III

C277Fb

UKF-NB-3rNutlin10 μM IV

Wild type

UKF-NB-6rNutlin10 μM IV

C135Fc, D281Yc

UKF-NB-3rNutlin10 μM V

Wild type

UKF-NB-6rNutlin10 μM V

C277Fb

UKF-NB-3rNutlin10 μM VI

P278Ac

UKF-NB-6rNutlin10 μM VI

R248Qc

UKF-NB-3rNutlin10 μM VII

D281Gc

UKF-NB-6rNutlin10 μM VII

C277Fb

UKF-NB-3rNutlin10 μM VIII

D281Gc

UKF-NB-6rNutlin10 μM VIII

C277Fb

UKF-NB-3rNutlin10 μM IX

D281Gc

UKF-NB-6rNutlin10 μM IX

C277Fb

  

UKF-NB-6rNutlin10 μM X

R248Qb

  1. aType of p53 mutation
  2. bHomozygote
  3. cHeterozygote